Search

everythinglearnresearchcommunity

for

Search:↓

Upadacitinib is safe and effective for treating alopecia areata and atopic dermatitis in children.

Lecithin-encapsulated resveratrol nanoparticles could be a safe and effective anti-cancer treatment.

Tofacitinib, a JAK inhibitor, improved hair regrowth in most patients with severe alopecia areata and had minimal side effects.

Baricitinib may effectively treat oral lichen planus.

Sintilimab treatment caused hair loss but led to complete tumor remission.

RTA 408 cream protects mice from radiation skin damage.

A man developed alopecia areata after starting cancer treatment with vandetanib.

Upadacitinib may effectively treat alopecia areata without side effects.

Tofacitinib may effectively treat skin symptoms in difficult cases of dermatomyositis.

Plerixafor may help treat pigmentation disorders by promoting skin repigmentation.

Eribulin-based chemotherapy is more effective and has fewer side effects for advanced triple-negative breast cancer.

Arsenic trioxide effectively treats relapsed acute promyelocytic leukemia with manageable side effects.

A Korean woman with complete hair loss regrew her hair after taking tofacitinib, with no side effects.

Tofacitinib taken by mouth helps treat hair loss in children.

The drug combination was safe and showed promise in treating advanced tumors.

EGFR inhibitors can cause unusual localized hair growth.

An HIV patient's complete hair loss was reversed after switching from lopinavir/ritonavir to nelfinavir.

Ruxolitinib cream shows promise for vitiligo, and early melanoma diagnosis is crucial.

Selumetinib causes skin and hair side effects in kids with NF1, affecting treatment and quality of life.

A woman with advanced eye cancer went into complete remission using a combination of immunotherapy and topical treatments.

Gefitinib can cause hair and eyebrow darkening.

A compound from Calophyllum inophyllum L. leaf may help treat non-small cell lung cancer.

Horizant has risks like other seizure drugs, Johnson & Johnson misled about Risperdal, and Quanterix found a possible link between brain oxygen loss and Alzheimer's markers.

Recognizing RSCC is crucial due to its aggressive nature and high risk of poor outcomes.

Some skin medications can have harmful interactions with the COVID-19 drug nirmatrelvir-ritonavir, but not with molnupiravir.

Disrupting the Flcn gene in mice causes early kidney cysts and tumors, which can be treated with rapamycin.

AZD6244 treatment causes skin aging effects by depleting skin stem cells.

Raltegravir may cause hair loss in some patients.